Stratified prevention: opportunities and limitations. Report on the 1st interdisciplinary cardiovascular workshop in Augsburg

Research output: Contribution to journalArticle

Authors

  • Gregor Kirchhof
  • Josef Franz Lindner
  • Stephan Achenbach
  • Klaus Berger
  • Stefan Blankenberg
  • Heiner Fangerau
  • Henner Gimpel
  • Ulrich M. Gassner
  • Jens Kersten
  • Dorothea Magnus
  • Herbert Rebscher
  • Heribert Schunkert
  • Stephan Rixen

Colleges, School and Institutes

External organisations

  • University of Augsburg
  • University Hospital of Erlangen
  • University of Münster
  • Universitäres Herzzentrum Hamburg-Eppendorf
  • University Hospital Düsseldorf
  • Ludwig-Maximilian-University
  • University of Hamburg
  • University of Bayreuth

Abstract

Sufficient exercise and sleep, a balanced diet, moderate alcohol consumption and a good approach to handle stress have been known as lifestyles that protect health and longevity since the Middle Age. This traditional prevention quintet, turned into a sextet by smoking cessation, has been the basis of the “preventive personality” that formed in the twentieth century. Recent analyses of big data sets including genomic and physiological measurements have unleashed novel opportunities to estimate individual health risks with unprecedented accuracy, allowing to target preventive interventions to persons at high risk and at the same time to spare those in whom preventive measures may not be needed or even be harmful. To fully grasp these opportunities for modern preventive medicine, the established healthy life styles require supplementation by stratified prevention. The opportunities of these developments for life and health contrast with justified concerns: A “surveillance society”, able to predict individual behaviour based on big data, threatens individual freedom and jeopardises equality. Social insurance law and the new German Disease Prevention Act (Präventionsgesetz) rightly stress the need for research to underpin stratified prevention which is accessible to all, ethical, effective, and evidence based. An ethical and acceptable development of stratified prevention needs to start with autonomous individuals who control and understand all information pertaining to their health. This creates a mandate for lifelong health education, enabled in an individualised form by digital technology. Stratified prevention furthermore requires the evidence-based development of a new taxonomy of cardiovascular diseases that reflects disease mechanisms. Such interdisciplinary research needs broad support from society and a better use of biosamples and data sets within an updated research governance framework.

Details

Original languageEnglish
JournalClinical Research in Cardiology
Early online date16 Dec 2017
Publication statusE-pub ahead of print - 16 Dec 2017

Keywords

  • genomics , prevention , heart failure , atrial fibrillation , stratified medicine , personalised medicine , payor , health economics